Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE4493.5020.55 (+0.46 %)

PREV CLOSE ( ) 4472.95

OPEN PRICE ( ) 4494.65

BID PRICE (QTY) 4487.25 (15)

OFFER PRICE (QTY) 4491.60 (4)

VOLUME 11182

TODAY'S LOW / HIGH ( )4464.65 4560.00

52 WK LOW / HIGH ( )3139.5 4714.5

NSE4492.2019.3 (+0.43 %)

PREV CLOSE( ) 4472.90

OPEN PRICE ( ) 4490.00

BID PRICE (QTY) 4490.50 (5)

OFFER PRICE (QTY) 4492.20 (25)

VOLUME 251348

TODAY'S LOW / HIGH( ) 4464.00 4560.10

52 WK LOW / HIGH ( )3140.1 4712.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1972

Management Info

Samir Mehta - Chairman Aman Mehta - Managing Director

Registered Office

Address Avirat,Thaltej Shilaj Road, ,
Ahmedabad,
Gujarat-380059

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

25May Torrent Pharma’s consolidated net prof
Torrent Pharmaceuticals has reported results for the fourth quarter (Q4F..

25May Torrent Pharma jumps despite consolida
Torrent Pharmaceuticals is currently trading at Rs. 4562.70, up by 78.55..

13Apr USFDA concludes inspection at Torrent
U.S. Food and Drug Administration (USFDA) has concluded the inspection a..

21Mar Torrent Pharmaceuticals launches Semag
Torrent Pharmaceuticals has launched its Semaglutide brands - Sembolic a..

13Feb Torrent Pharmaceuticals reports 26% ri
Torrent Pharmaceuticals has reported results for third quarter ended Dec..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	4670	21920
Gross Profit	5920	28970
Operating Profit	10610	40720
Net Sales	27350	107120

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kwality Pharma (BSE) 2498.25 (6.93%)	M.Cap ( in Cr)2592.23
Abbott India (BSE) 26250.00 (0.40%)	M.Cap ( in Cr)55811.29
Venus Remedies (BSE) 1682.35 (5.00%)	M.Cap ( in Cr)2248.80
Caplin Point Lab (BSE) 2331.65 (3.28%)	M.Cap ( in Cr)17748.73
Concord Biotech (BSE) 1344.10 (5.71%)	M.Cap ( in Cr)14069.31

Shareholding Pattern

	PROMOTERS	68.31%
	NON-INSTITUTION	6.45%
	MUTUAL FUNDS/UTI	4.45%
	FI/BANKS/INSURANCE	1.97%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pha...	5.41
LIC MF Healthcare F...	5.10
ICICI Pru Nifty Pha...	4.51
Nippon India Nifty ...	4.50
PGIM India Healthca...	4.08
ITI Pharma & Health...	4.03
HDFC Pharma and Hea...	3.83

Risk Disclosures on Derivatives

Smart Quotes

TORRENT PHARMACEUTICALS LTD.